|
NOL8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63069557856943E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59590127171805E-11 |
| Normal-vs-Stage2 |
1.61209999793854E-08 |
| Normal-vs-Stage3 |
1.98507876802978E-13 |
| Normal-vs-Stage4 |
2.57349697108111E-12 |
| Stage1-vs-Stage2 |
1.571380E-01 |
| Stage1-vs-Stage3 |
1.708440E-02 |
| Stage1-vs-Stage4 |
1.735160E-03 |
| Stage2-vs-Stage3 |
7.832800E-01 |
| Stage2-vs-Stage4 |
2.242200E-01 |
| Stage3-vs-Stage4 |
2.154400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7430501486615E-14 |
| Normal-vs-AfricanAmerican |
2.31610000067661E-08 |
| Normal-vs-Asian |
1.03439999998844E-06 |
| Caucasian-vs-AfricanAmerican |
2.341400E-01 |
| Caucasian-vs-Asian |
4.256300E-02 |
| AfricanAmerican-vs-Asian |
1.480050E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.17730319621523E-11 |
| Normal-vs-Female |
1.63757896132211E-12 |
| Male-vs-Female |
7.322000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.75509964736887E-10 |
| Normal-vs-Age(41-60Yrs) |
2.07944772512292E-13 |
| Normal-vs-Age(61-80Yrs) |
3.83804099612917E-12 |
| Normal-vs-Age(81-100Yrs) |
1.96988999999759E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.159350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.025610E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.735700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.718630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.965410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.963000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.015580E-01 |
| Classical-VS-Follicular |
2.377200E-01 |
| Classical-VS-Other |
7.076000E-01 |
| Classical-VS-Normal |
1.82276416182958E-12 |
| Tall-VS-Follicular |
6.162200E-01 |
| Tall-VS-Other |
6.961600E-01 |
| Tall-VS-Normal |
2.33629999790708E-08 |
| Follicular-VS-Other |
9.333400E-01 |
| Follicular-VS-Normal |
4.33150004752747E-09 |
| Other-VS-Normal |
5.018800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03472785895065E-12 |
| Normal-vs-N1 |
1.49000034532776E-10 |
| N0-vs-N1 |
3.124000E-01 |
|
|
